Svetlana A Smirnikhina (S Smirnikhina, S A Smirnikhina, Svetlana Smirnikhina)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Duchenne Muscular Dystrophy

Chronic Myeloid Leukemia

Top Venues

Transgenic research

BioEssays : news and reviews in molecular, cellular and developmental biology

Molecular biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Olga V Volodina, Anastasia R Fabrichnikova, Arina A Anuchina, Olesya S Mishina, Alexander V Lavrov, Svetlana A Smirnikhina
Evolution of Prime Editing Systems: Move Forward to the Treatment of Hereditary Diseases. Current gene therapy (2024)
Olga V Volodina, Svetlana A Smirnikhina
The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based Therapies. Molecular biotechnology (2024)
Lyubava Belova, Anna G Demchenko, Konstantin S Kochergin-Nikitsky, E Kondrateva, Yana S Slesarenko, Diana I Salikhova, Alexander V Lavrov, A Efremova, Tatiana Borisovna Bukharova, D V Goldshtein, Svetlana A Smirnikhina
Recombinant Adeno-associated Viral Vectors Serotypes 6 and 9 are Able to Transduce Human Tracheal Epithelial Cells but Not Human Induced Pluripotent Stem Cells. Molecular biotechnology (2023)
Irina O Petrova, Svetlana A Smirnikhina
Studies on glycogen storage disease type 1a animal models: a brief perspective. Transgenic research (2022)
Lyubava Belova, Konstantin S Kochergin-Nikitsky, Anastasia Erofeeva, Alexander V Lavrov, Svetlana A Smirnikhina
Approaches to purification and concentration of rAAV vectors for gene therapy. BioEssays : news and reviews in molecular, cellular and developmental biology 44 (6) (2022)
Lyubava Belova, Alexander V Lavrov, Svetlana A Smirnikhina
Organoid transduction using recombinant adeno-associated viral vectors: Challenges and opportunities. BioEssays : news and reviews in molecular, cellular and developmental biology 44 (9) (2022)
Yana S Slesarenko, Alexander V Lavrov, Svetlana A Smirnikhina
Off-target effects of base editors: what we know and how we can reduce it. Current genetics (2021)
Konstantin S Kochergin-Nikitsky, Lyubava Belova, Alexander V Lavrov, Svetlana A Smirnikhina
Tissue and cell-type-specific transduction using rAAV vectors in lung diseases. Journal of molecular medicine (Berlin, Germany) 99 (8) (2021)
M I Zaynitdinova, Alexander V Lavrov, Svetlana A Smirnikhina
Animal models for researching approaches to therapy of Duchenne muscular dystrophy. Transgenic research 30 (6) (2021)
Svetlana A Smirnikhina, Ekaterina V Kondrateva, Elmira P Adilgereeva, Arina A Anuchina, Milyausha I Zaynitdinova, Yana S Slesarenko, Angelina S Ershova, Kirill D Ustinov, Matvei I Yasinovsky, Elena L Amelina, Ekaterina S Voronina, Valentina D Yakushina, Vyacheslav Yu Tabakov, Alexander V Lavrov
P.F508del editing in cells from cystic fibrosis patients. PloS one 15 (11) (2020)
Arina A Anuchina, Alexander V Lavrov, Svetlana A Smirnikhina
TIRR: a potential front runner in HDR race-hypotheses and perspectives. Molecular biology reports 47 (3) (2020)
Alexander V Lavrov, Ekaterina Yu Chelysheva, Elmira P Adilgereeva, Oleg A Shukhov, Svetlana A Smirnikhina, Konstantin S Kochergin-Nikitsky, Valentina D Yakushina, Grigory A Tsaur, Sergey V Mordanov, Anna G Turkina, Sergey I Kutsev
Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients. BMC medical genomics 12 (Suppl 2) (2019)
Svetlana A Smirnikhina, Ekaterina Yu Chelysheva, Alexander V Lavrov, Konstantin S Kochergin-Nikitsky, Ivan V Mozgovoy, Elmira P Adilgereeva, Oleg A Shukhov, Anna N Petrova, Anastasia V Bykova, Adhamjon O Abdullaev, Anna G Turkina, Sergey I Kutsev
Genetic markers of stable molecular remission in chronic myeloid leukemia after targeted therapy discontinuation. Leukemia & lymphoma 59 (10) (2018)
Svetlana A Smirnikhina, Arina A Anuchina, Alexander V Lavrov
Ways of improving precise knock-in by genome-editing technologies. Human genetics 138 (1) (2018)
Alexander V Lavrov, Oksana A Ustaeva, Elmira P Adilgereeva, Svetlana A Smirnikhina, Ekaterina Y Chelysheva, Oleg A Shukhov, Yuriy V Shatokhin, Sergey V Mordanov, Anna G Turkina, Sergey I Kutsev
Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia. PloS one 12 (9) (2017)